Nerve Degeneration: Clinical Trials

2 trials for Nerve Degeneration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 32Terminated 2

Follow Nerve Degeneration: new trials by email Literature Review of Nerve Degeneration trials Research Report on Nerve Degeneration

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy
Phase 2 / Phase 3TerminatedPTC Therapeutics682020-09-282026-03-31
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Lithium Carbonate, Riluzole, placebo - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3TerminatedMassachusetts General Hospital842009-01-012011-04-19

Narrower conditions

Amyotrophic Lateral Sclerosis (1)  ·  Diffuse Cerebral Sclerosis of Schilder (1)  ·  Drug Resistant Epilepsy (1)  ·  Leigh Disease (1)  ·  MELAS Syndrome (1)  ·  MERRF Syndrome (1)  ·  Mitochondrial Diseases (1)  ·  Mitochondrial encephalopathy (1)  ·  Pontocerebellar Hypoplasia Type 6 (1)  ·  Seizures (1)  ·  Status Epilepticus (1)

Broader conditions

Central Nervous System Diseases (2)  ·  Metabolic Diseases (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Small Vessel Diseases (1)

Interventions

Lithium Carbonate (1)  ·  Riluzole (1)  ·  alpha-tocotrienol quinone (1)

Sponsors

Massachusetts General Hospital (1)  ·  PTC Therapeutics (1)

Countries

Canada (2)  ·  United States (2)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Jinsy Andrews, MD (1)  ·  Lorne Zinman, MD, MSc, FRCPC (1)  ·  Merit Cudkowicz, MD, MSc (1)  ·  Swati Aggarwal, MD (1)  ·  Vinay Penematsa, MD (1)

Results publications

PMID 20363190, PMID 37794802

NIH funding

U01NS049640 (1)